1-Boc-3-(3-oxo-1-piperazinyl)azetidine

Catalog No. :
ACKAOH437
CAS No. :
1257293-71-2
Molecular Formula :
C12H21N3O3
Molecular Weight :
255.32

IUPAC Name:tert-butyl 3-(3-oxopiperazin-1-yl)azetidine-1-carboxylate

1-Boc-3-(3-oxo-1-piperazinyl)azetidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$566.00Login to see priceInquiryInquiry
250mg95%$756.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Boc-3-(3-oxo-1-piperazinyl)azetidine
IUPAC Nametert-butyl 3-(3-oxopiperazin-1-yl)azetidine-1-carboxylate
MDL No.MFCD23105981
Molecular FormulaC12H21N3O3
Molecular Weight255.32
SMILESO=C1CN(C2CN(C(OC(C)(C)C)=O)C2)CCN1
InChI KeyZYOPXPCGSUAHOF-UHFFFAOYSA-N
Synonymtert-butyl 3-(3-oxopiperazin-1-yl)azetidine-1-carboxylate;1-Boc-3-(3-oxo-1-piperazinyl)azetidine;1-Azetidinecarboxylic acid, 3-(3-oxo-1-piperazinyl)-, 1,1-dimethylethyl ester;3-(3-oxo-piperazin-1-yl)-azetidine-1-carboxylic acid tert-butyl ester
CAS No.1257293-71-2
PubChem CID59605439

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACKAOH437 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCXNG132 route compound structure diagram
    ACCXNG1325625-67-2 In Stock
  4. Then
  5. ACKAOH437 route product structure diagram
    ACKAOH4371257293-71-2
Inquiry

2. ACKAOH437 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUMRD963 route compound structure diagram
    ACUMRD963141699-58-3 In Stock
  2. Plus
  3. ACCXNG132 route compound structure diagram
    ACCXNG1325625-67-2 In Stock
  4. Then
  5. ACKAOH437 route product structure diagram
    ACKAOH4371257293-71-2
Inquiry

Comments (0)